tradingkey.logo

Envoy Medical Inc

COCH
0.738USD
+0.012+1.71%
Horário de mercado ETCotações atrasadas em 15 min
15.87MValor de mercado
PerdaP/L TTM

Envoy Medical Inc

0.738
+0.012+1.71%

Mais detalhes de Envoy Medical Inc Empresa

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

Informações de Envoy Medical Inc

Código da empresaCOCH
Nome da EmpresaEnvoy Medical Inc
Data de listagemMar 02, 2021
CEOMr. Brent T. Lucas
Número de funcionários42
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 02
Endereço4875 White Bear Parkway
CidadeWHITE BEAR LAKE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal55110
Telefone16513618000
Sitehttps://www.envoymedical.com/
Código da empresaCOCH
Data de listagemMar 02, 2021
CEOMr. Brent T. Lucas

Executivos da empresa Envoy Medical Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
216.49K
+3.35%
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--
Ms. Mona Patel
Ms. Mona Patel
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
216.49K
+3.35%
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--

Detalhamento da receita

Sem dados
Sem dados
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
NorthRock Partners, LLC
35.88%
Taylor (Glen A)
35.88%
Atlas Merchant Capital LLC
1.94%
The Vanguard Group, Inc.
1.38%
Weiss Asset Management
1.28%
Outro
23.64%
Investidores
Investidores
Proporção
NorthRock Partners, LLC
35.88%
Taylor (Glen A)
35.88%
Atlas Merchant Capital LLC
1.94%
The Vanguard Group, Inc.
1.38%
Weiss Asset Management
1.28%
Outro
23.64%
Tipos de investidores
Investidores
Proporção
Investment Advisor
39.37%
Individual Investor
37.15%
Private Equity
1.94%
Hedge Fund
1.67%
Investment Advisor/Hedge Fund
1.40%
Outro
18.47%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
57
12.73M
44.52%
+8.56M
2025Q2
70
23.44M
108.95%
+6.87M
2025Q1
77
13.16M
66.71%
-3.62M
2024Q4
150
12.62M
59.27%
-33.88M
2024Q3
159
13.83M
66.11%
-35.76M
2024Q2
163
13.88M
70.79%
-37.22M
2024Q1
162
13.71M
69.92%
-38.36M
2023Q4
154
4.83M
24.67%
-35.19M
2023Q3
153
6.18M
31.55%
-33.86M
2023Q2
150
4.03M
92.35%
-36.92M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
NorthRock Partners, LLC
10.29M
46.98%
+10.29M
--
Jun 30, 2025
Taylor (Glen A)
10.29M
46.98%
--
--
Apr 10, 2025
Atlas Merchant Capital LLC
555.53K
2.54%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
394.96K
1.8%
--
--
Jun 30, 2025
Weiss Asset Management
368.14K
1.68%
-19.82K
-5.11%
Jun 30, 2025
Lucas (Brent T)
209.46K
0.96%
+7.74K
+3.84%
May 30, 2025
Focus Partners Wealth, LLC
212.66K
0.97%
--
--
Jun 30, 2025
DSG Capital Advisors, LLC
163.64K
0.75%
--
--
Jun 30, 2025
Arcus Capital Partners, LLC
187.57K
0.86%
--
--
Jun 30, 2025
Meteora Capital LLC
108.51K
0.5%
--
--
Apr 10, 2025
Ver Mais

ETFs Relacionados

Atualizado em: dom, 2 de nov
Atualizado em: dom, 2 de nov
Nome
Proporção
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI